XSES
C05
Market cap27mUSD
Oct 30, Last price
0.47SGD
1Q
-30.37%
Jan 2017
-33.80%
Name
Chemical Industries (Far East) Ltd
Chart & performance
P/E
—
P/S
0.59
EPS
—
Vol. 1Y
76.82%
Shs. 5Y
—
Rev. 5Y
-0.76%
Div Yld LY
1.06%
Div Yld TTM
1.06%
Revenues
61m
-7.25%
Net income
-919k
L-95.72%
CFO
3m
-63.84%
Dividend
Aug 05, 20260.005 SGD/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Incorporated in Singapore in 1962, Chemical Industries (Far East) Limited functions as an investment holding entity primarily involved in the production and sale of chemicals across Singapore and Myanmar. Its operations are organized into two distinct divisions: Industrial Chemicals and Properties. Within its chemical arm, the company manufactures essential compounds such as sodium hypochlorite, chlorine, hydrochloric acid, and calcium hydroxide, vital for applications in water purification and the electronics sector. Beyond manufacturing, it also offers comprehensive distribution and logistics solutions for chemicals. Additionally, the firm oversees and leases commercial real estate. Completing its portfolio, it acts as a broad-based merchant, facilitating the import and export of a range of chemical products.
Key people
Soo Peng Lim
Emeritus Chairman and Non-Executive Director · since 2022
Hock Chye Yeo
Non-Executive Independent Chairman of the Board · since 2020
Wong Tian Song
Chief Executive Officer · since 2024
Tian Song Wong
Chief Executive Officer · since 2024
Yew Nghee Lim
Non-Executive Non-Independent Deputy Chairman of the Board · since 2023
Pua Yong Tan
General Manager · since 2013
Hwei Fern Chang
Group Financial Controller · since 2026
May Lin Yeap
Group Financial Controller · since 2020
Kim Tse Loh
Head of Commercial · since 2013
Ek Pheng Teo
Logistics Manager
Moon Seng Wong
Technical Adviser to Chairman
Keng Liang Yeo
Sales & Marketing Manager
Soon Soo Foo
Company Secretary · since 2014
Koon Eng Goh
Non-Executive Independent Director · since 2024
Chee San Lim
Non-Executive Independent Director · since 2021
Valuation
Title SGD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026‑03 | 2025‑03 | 2024‑03 | 2023‑03 | 2022‑03 | 2021‑03 | 2020‑03 | 2019‑03 | 2018‑03 | 2017‑03 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||